AZ Sint-Blasius

Dendermonde 9200

1 studies enrolling now · 13 studies all time

What they study most

Alzheimer Disease, Artery Disease, Peripheral, Atherosclerotic Cardiovascular Disease (ASCVD), Atrial Fibrillation, Coronary Heart Disease (CHD), Critical Limb Ischemia, Deep Vein Thrombosis, Elevated Lp(a), Femoropopliteal Artery Occlusion, Heart Failure, Hyperkalemia, Ischemic Stroke; Ischemic Attack, Transient

Studies at this site

• A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart — Recruiting now
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• Safety and Efficacy of the SurVeil™ Drug-Coated Balloon — Completed
• Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia — Completed
• The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia — Completed
• A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) — Completed
• The SENTRY Clinical Study — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) — Completed
• BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease. — Completed